Irritable Bowel Syndrome: all 1,084 studies

Page 3 of 11. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.

• Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)CompletedNCT05130047Phase 2Results posted
• The Role of Fiber in the Prevention and Treatment of Fecal IncontinenceCompletedNCT04806386Not applicableResults posted
• Zemedy Application for Irritable Bowel SyndromeTerminatedNCT04723056Not applicableResults posted
• SH-DS01 on Fecal Metagenomic StabilityCompletedNCT04598295Phase 2Results posted
• Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT04542018Not applicableResults posted
• Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel SyndromeCompletedNCT04428619Not applicableResults posted
• A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal DisordersTerminatedNCT04247100Not applicableResults posted
• Acceptability and Efficacy of the Zemedy App for Irritable Bowel SyndromeCompletedNCT04170686Not applicableResults posted
• Efficacy and Safety of IBS Digital Behavioral TreatmentCompletedNCT04133519Not applicableResults posted
• Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)TerminatedNCT04043455Phase 2Results posted
• Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)CompletedNCT04026113Phase 3Results posted
• Irritable Bowel Syndrome and Control Volunteers: Diet ChallengeTerminatedNCT03983434Not applicableResults posted
• Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT03977155Phase 2Results posted
• A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT03931785Phase 2Results posted
• Does Improving Vagal Tone Increase Mitochondrial BioenergeticsCompletedNCT03931330Not applicableResults posted
• Vestibulodynia: Understanding Pathophysiology and Determining Appropriate TreatmentsCompletedNCT03844412Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel SyndromeCompletedNCT03806127Phase 2Results posted
• Efficacy and Safety of SYN-010 in IBS-CTerminatedNCT03763175Phase 2Results posted
• A Trial for New Treatment of Adult Participants With Irritable Bowel SyndromeCompletedNCT03721107Phase 2Results posted
• Dietary Triggers of Gastrointestinal Symptoms in IBS PatientsCompletedNCT03664531Not applicableResults posted
• A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT03573908Phase 3Results posted
• Rifaximin on Visceral HypersensitivityTerminatedNCT03462966Phase 2Results posted
• Eluxadoline Bile Acid Malabsorption (BAM) StudyCompletedNCT03441581Phase 4Results posted
• Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid MalabsorptionCompletedNCT03270085Phase 2Results posted
• A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath TestingCompletedNCT03219528Phase 4Results posted
• A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy VolunteersCompletedNCT03154086Phase 1Results posted
• The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With ConstipationCompletedNCT03054506Not applicableResults posted
• Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide UseCompletedNCT02959983Phase 4Results posted
• A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)TerminatedNCT02837783Phase 4Results posted
• Effects of Open-label vs Double-blind Treatment in IBSCompletedNCT02802241Not applicableResults posted
• Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT02757105Phase 2Results posted
• A Long-Term Safety Study of Tenapanor for the Treatment of IBS-CCompletedNCT02727751Phase 3Results posted
• Long Term Safety Study of PlecanatideCompletedNCT02706483Phase 3Results posted
• A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-CCompletedNCT02686138Phase 3Results posted
• A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-CCompletedNCT02621892Phase 3Results posted
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic ConstipationCompletedNCT02590432Phase 4Results posted
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With ConstipationTerminatedNCT02559817Phase 2Results posted
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT02559206Phase 2Results posted
• Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel SyndromeTerminatedNCT02544152Phase 2Results posted
• A Study of the Effect of SYN-010 on Subjects With IBS-CCompletedNCT02495623Phase 2Results posted
• Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT02493452Phase 3Results posted
• A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-CCompletedNCT02493036Phase 2Results posted
• The Efficacy of PX0612 In The Treatment Of Irritable Bowel SyndromeCompletedNCT02431533Not applicableResults posted
• Efficacy of Open Label Placebo in Children With FGIDsCompletedNCT02389998Not applicableResults posted
• A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-GCompletedNCT02388269Not applicableResults posted
• Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel SyndromeCompletedNCT02328547Phase 2Results posted
• Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic StudyCompletedNCT02291445Phase 2Results posted
• Biomarkers for Intestinal Permeability in Patients With ConstipationCompletedNCT02246647Results posted
• Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-DTerminatedNCT02239926Phase 2/3Results posted
• 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)TerminatedNCT02120027Phase 3Results posted
• Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile AcidsCompletedNCT02111603Phase 4Results posted
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)CompletedNCT02107196Phase 3Results posted
• The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)CompletedNCT01923428Phase 2/3Results posted
• Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel SyndromeCompletedNCT01886781Phase 4Results posted
• A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT01880424Phase 3Results posted
• Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel SyndromeCompletedNCT01786109Phase 2Results posted
• Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major DepressionCompletedNCT01754493Phase 4Results posted
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)CompletedNCT01722318Phase 2Results posted
• Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG ProtocolCompletedNCT01697397Results posted
• Efficacy of Gralise® for Chronic Pelvic PainTerminatedNCT01678911Phase 4Results posted
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)CompletedNCT01553747Phase 3Results posted
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)CompletedNCT01553591Phase 3Results posted
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment StudyCompletedNCT01543178Phase 3Results posted
• Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)TerminatedNCT01471379Phase 2Results posted
• Glutamine for the Treatment of Patients With Irritable Bowel SyndromeCompletedNCT01414244Phase 2Results posted
• The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot StudyCompletedNCT01412372Phase 3Results posted
• Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)CompletedNCT01404923Phase 4Results posted
• Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mgTerminatedNCT01358708Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)CompletedNCT01340053Phase 2Results posted
• Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive DisorderTerminatedNCT01337609Phase 4Results posted
• Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel SyndromeCompletedNCT01331213Phase 4Results posted
• Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)CompletedNCT01327300Phase 2Results posted
• Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)CompletedNCT01303224Phase 2Results posted
• Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)CompletedNCT01253408Phase 2Results posted
• Irritable Bowel Syndrome HypnotherapyCompletedNCT01248013Not applicableResults posted
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With DiarrheaCompletedNCT01177410Phase 2Results posted
• Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With ConstipationCompletedNCT01162863Not applicableResults posted
• Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With DiarrheaCompletedNCT01130272Phase 2Results posted
• Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In AdolescentsCompletedNCT01118988Not applicableResults posted
• Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI DisordersCompletedNCT01099111Results posted
• Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)CompletedNCT01085643Not applicableResults posted
• Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) PatientsCompletedNCT01056107Phase 1/2Results posted
• A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel SyndromeCompletedNCT00977197Phase 2Results posted
• An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety DisorderCompletedNCT00961298Phase 4Results posted
• Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With ConstipationCompletedNCT00948818Phase 3Results posted
• Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel SyndromeCompletedNCT00945334Not applicableResults posted
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT00938717Phase 3Results posted
• Cheno Effect on Transit in Health and IBS-CCompletedNCT00912301Phase 2Results posted
• Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)?CompletedNCT00911612Phase 2Results posted
• Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With DesipramineTerminatedNCT00880594Not applicableResults posted
• Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey DataCompletedNCT00880256Not applicableResults posted
• Study of LX1031 in Subjects With Non-Constipating Irritable Bowel SyndromeCompletedNCT00813098Phase 2Results posted
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With ConstipationCompletedNCT00765999Phase 3Results posted
• Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)CompletedNCT00761007Phase 2Results posted
• Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel SyndromeTerminatedNCT00742872Phase 3Results posted
• Self Administered Cognitive Behavior Therapy for Irritable Bowel SyndromeCompletedNCT00738920Not applicableResults posted
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)CompletedNCT00731679Phase 3Results posted
• An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With ConstipationCompletedNCT00730171Phase 3Results posted
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)CompletedNCT00724126Phase 3Results posted
• Gulf War Digestive Health StudyCompletedNCT00680836Not applicableResults posted

← Irritable Bowel Syndrome overview